Crinetics Pharmaceuticals, Inc. (CRNX)

Last Closing Price: 33.52 (2025-05-01)

Pre-Tax Income (Annual)

Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.

Crinetics Pharmaceuticals, Inc. (CRNX) had Pre-Tax Income of $-297.94M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$1.04M
$-298.41M
--
$1.04M
$339.89M
$-338.85M
$40.92M
Pre-Tax Income
$-297.94M
$-297.94M
$-297.94M
$-298.41M
$-298.41M
$-297.94M
$-338.85M
$-351.00M
80.78M
80.78M
$-3.69
$-3.69
Balance Sheet Financials
$1.38B
$12.07M
$59.20M
$1.43B
$59.68M
--
$50.10M
$109.79M
$1.32B
$1.32B
$1.32B
92.93M
Cash Flow Statement Financials
$-225.97M
$-574.82M
$1.01B
$56.20M
$265.85M
$209.65M
$69.39M
--
--
Fundamental Metrics & Ratios
23.04
--
--
--
--
100.00%
-32613.47%
-32613.47%
-33782.48%
-28675.46%
-28720.69%
$-229.81M
--
--
--
0.00
--
--
--
-22.52%
-22.52%
-20.80%
-22.52%
$14.26
$-2.84
$-2.80